Sabar Karimah Es sold CAPR
April 2, 2026 · Form 4 insider transaction
Sabar Karimah Es sold 7,529 shares of Capricor Therapeutics, Inc. at $32.00 per share, a transaction worth $240.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
7,529
Price
$32.00
Total value
$240.9K
InsiderSabar Karimah Es
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 2, 2026
Filing dateApril 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.